NDC 0955-2900 – Insulin glargine U-300 Max
Insulin Glargine 300 [iU]/mL · Injection, Solution · Subcutaneous
Product NDC0955-2900
Product details
- Brand name
- Insulin glargine U-300 Max
- Generic name
- Insulin glargine
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA206538
- Marketed since
- April 1, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Insulin Analog
Active ingredients
- Insulin Glargine 300 [iU]/mL
Uses, dosage, side effects and warnings for Insulin glargine U-300 Max →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0955-2900-02 | 2 SYRINGE in 1 CARTON (0955-2900-02) / 3 mL in 1 SYRINGE (0955-2900-01) | Apr 1, 2023 |